Nevertheless, PTH and both doses of ABL decreased bone mRNA Sost expression and ABL also reduced circulating sclerostin protein levels (Fig. 5a), suggesting a potential role of Sost/sclerostin downregulation in the anabolic function of the PTH1R ligands in the context of diabetes. The gene discussed is PTH; the disease is diabetes mellitus.